IFF Management projects Capex at 5%-6% of sales after the Food Ingredients divestiture, with near-term spend skewing toward the upper end due to high-return initiatives. Reinvestment is anchored in Remainco growth through R&D at 8%-9% of sales and targeted cash-flow improvements, including a mid-to-high-teens free cash flow conversion.
Generated by Dafinchi AI. Source-grounded AI analysis, not investment advice.
What did management say about Capex and reinvestment post-divestiture?
Management guided that CapEx will be in the range of ~5% to 6% of sales. 1 Specifically, they said: “we will probably be in the range of 5% to 6%”, and discussed how that blended rate reflects differences across segments (with H&B running at a higher rate and Scent/Taste lower than a best-in-class peer), implying the company is targeting a consolidated, blended CapEx intensity consistent with reinvestment needs. 1
They also clarified the near-term trajectory: over the next 1–2 years, CapEx is expected to be at the upper end of the 5%–6% range (closer to 6%) because they have “critical initiatives” they view as high-return. 2
Management emphasized that reinvestment in the Remainco businesses is deliberate and recurring—particularly through R&D and innovation—and that this reinvestment cycle supports growth and margin expansion. 1 In particular, they said it is “really important that we critically continue to reinvest in this business” to “make sure we set ourselves apart,” describing a flywheel: investments → better growth → ability to expand margin and continue reinvesting. 1
While the question is about Capex specifically, management’s framework for “reinvestment” is broader than plant and equipment; they also highlighted R&D reinvestment. 1 They stated R&D is around 8% to 9% of sales for Remainco and is crucial to the strategy. 1 (They further added in Q&A that Remainco R&D increased from ~7% historically to about 9% today and they intend to continue increasing as they grow sales, potentially increasing further if it creates additional value. 3)
On the divestiture and “how much investment can we afford,” management tied cash generation to the ability to fund improvements. In the Q&A, they referenced that the separation improves the free cash flow profile, and a question asked for the capital budget and the quantitative/qualitative impact on CapEx as they pivot to reinvestment and innovation. 4 Management’s direct numeric Capex guidance (5%–6%, upper end near-term) provides the anchor for that capital budget framing. 12
Separately, management described the free cash flow definition and expected cash conversion for Remainco as “EBITDA minus CapEx divided by sales” targeting mid- to high teens for the three Remainco businesses (Scent, Taste, H&B). 5 This indicates they expect Capex to be a controlled use of cash while sustaining reinvestment-driven earnings quality. 5 They also noted Food Ingredients has a lower cash flow profile, contributing to a mix shift, and they expect overall improvement by 2027 and 2028 go-forward. 5
While not Capex, management’s discussion of stranded costs helps explain why reinvestment and transformation might require a higher Capex level early. They guided that CapEx should be near the upper end (closer to 6%) in the next 1–2 years for “critical initiatives.” 2 In parallel, they described ~$100 million of stranded costs that temporarily pressur[e] Remainco unit margins and that they expect to eliminate about 2/3 within the first 12 months after the close and the remainder in the second full year post-close. 6
This combination—temporary margin pressure plus high-return transformation initiatives—provides the operational rationale management gave for why Capex may sit closer to 6% in the near term rather than settling immediately at the low end. 26
Disclaimer: The output generated by dafinchi.ai, a Large Language Model (LLM), may contain inaccuracies or "hallucinations." Users should independently verify the accuracy of any mathematical calculations, numerical data, and associated units, as well as the credibility of any sources cited. The developers and providers of dafinchi.ai cannot be held liable for any inaccuracies or decisions made based on the LLM's output.
Post-divestiture, IFF signals a Capex target of 5-6% of sales, with near-term leaning toward ~6% to fund high-return initiatives. Reinvestment is anchored in R&D/innovation for the Remainco, with R&D running around 8-9% of sales and potential increases as sales grow.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines post-divestiture Capex targets of roughly 5-6% of sales, with near-term guidance near the upper end to fund high-return initiatives, while prioritizing R&D reinvestment to support the Remainco growth and margin expansion. The discussion also covers stranded costs, cash-flow framing, and near-term working-capital headwinds tied to the divestiture.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF signals a disciplined capital allocation plan focused on a 5%-6% Capex target, with a near-term tilt toward 6%. It also emphasizes sustained R&D investment (about 8%-9% of sales, now around 9%) to drive growth and margin expansion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF outlines a disciplined capex framework of about 5-6% of sales, with a near-term tilt toward the upper end to fund high-return initiatives. Reinvestment remains anchored in R&D at 8-9% of sales within the Remainco strategy, alongside a stranded-cost remediation plan to protect margins and lift cash flow as the company progresses toward 2027 and 2028.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, management outlines a Capex path of about 5-6% of sales, with near-term spending at ~6% to fund high-return initiatives, while reinvestment—especially in R&D—remains central to the Remainco strategy and margin expansion. They expect the remaining portfolio to generate sufficient cash flow to support this plan, despite divestiture-related working-capital headwinds.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF explains Capex targeting 5-6% of sales post-divestiture, with near-term activity closer to 6% due to high-return initiatives. The company reaffirms a Remainco strategy focused on ongoing reinvestment, especially in R&D and innovation, to sustain growth and margin expansion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines a post-divestiture capex plan of about 5%–6% of sales, with near-term movement toward the upper end due to high-return initiatives. Management ties reinvestment to an innovation loop—driving higher R&D spend (approximately 9% of sales) and stronger Remainco cash flow—while noting working-capital headwinds related to the divestiture and expecting 2026 free cash flow to exceed 2025.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF signals a disciplined capex path of 5–6% of sales with a near-term tilt to ~6% for high-return projects, funded by a Remainco strategy that relies on 8–9% of sales for R&D. Stranded costs of about $100 million are to be phased out over 12–24 months, underpinning anticipated better cash flow.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines a disciplined reinvestment plan after the divestiture, targeting capex of 5-6% of sales (around 6% near term) to fund high-return initiatives. R&D is maintained at 8-9% of sales to sustain growth and margin expansion.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
IFF outlines a post-divestiture capital plan: CapEx remains targeted at 5–6% of sales, with management aiming near 6% in the next 1–2 years to fund high-return initiatives and ongoing innovation. The focus shifts to the Remainco businesses while roughly $100 million of stranded costs linger, with two-thirds expected to be eliminated within 12 months and the remainder in the following year.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Post-divestiture, IFF signals a disciplined reinvestment path: Capex targeted at 5-6% of sales with a bias toward 6% in the near term, and R&D around 8-9% of sales. The plan pairs ongoing reinvestment with debt reduction and a significant buyback, and positions Remainco as a cash-generative engine with 2026 free cash flow to improve despite near-term margin pressures.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Following the divestiture of Food Ingredients, management frames CapEx at 5-6% of sales, with closer to 6% in the near term to fund high-return initiatives within the Remainco transformation. R&D remains a key driver, rising to about 9% of sales, and the company emphasizes strong cash generation and a disciplined reinvestment cycle designed to lift growth and margins as sales expand.
Sources used
Research questionWhat did management say about Capex and reinvestment post-divestiture?
Answer outline
Dafinchi